Skip to content

Epidemiological survey of respiratory virus infection in patients with acute exacerbation of chronic obstructive pulmonary disease

Epidemiological survey of respiratory virus infection in patients with acute exacerbation of chronic obstructive pulmonary disease

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000040771
Enrollment
Unknown
Registered
2020-12-09
Start date
2021-01-01
Completion date
Unknown
Last updated
2022-10-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic obstructive pulmonary disease

Interventions

AECOPD Group:No
Lower Repiratory Tract Infection Group :no

Sponsors

Shengjing Hospital of China Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Inclusion criteria for acute exacerbation of COPD: (1) Male or female, aged > 40 years; (2) Have exposure to at least one risk factor, such as smoking, biofuels, host factors, etc., of which the smoking index is >= 10 pack years, and the use of biofuels is >= 10 years; Host factors include premature delivery, childhood respiratory diseases, family history and occupation; (3) Have respiratory symptoms such as chronic cough, expectoration or shortness of breath; (4) In the past 1 year, pulmonary function showed that FEV1/FVC 40 years; (2) Meet one of the following conditions: 1) Have respiratory symptoms such as cough and expectoration; 2) Fever, body temperature >= 37.3 degree C; 3) Wet rales can be heard in the lungs. (3) Lung CT has signs of lower respiratory tract infection (including but not limited to: patch shadow, consolidation shadow, ground glass exudation, etc.); (4) More than one month before admission or before discharge, pulmonary function showed: FEV1/FVC >= 80%; (5) Hospitalization due to lower respiratory tract infection, the course of disease <= 7 days. (6) Sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1.Have received flu vaccine or other virus vaccine in the past year; 2.Long-term use of systemic glucocorticoids; 3.Combined with severe organ dysfunction; 4.Suffering from active infection: such as tuberculosis; 5.The Enrolled subjects will not participate repeatedly; 6.Use of other investigational intervention within within 30 days.

Design outcomes

Primary

MeasureTime frame
pathogenic distribution of respiratory viruses;

Countries

China

Contacts

Public ContactLi Zhao

Shengjing Hospital of China Medical University

zhaol@sj-hospital.org+86 18940251639

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026